Novo Integrated Sciences, through its wholly owned subsidiary, Novo Healthnet Limited (NHL), delivers multidisciplinary primary health care related services and products through the integration of medical technology, interconnectivity, improved therapeutics, diagnostic solutions, personalized product offerings, and rehabilitative science. Co.'s clinicians and practitioners provide certain multidisciplinary primary health care services, and related products. NHL's team of multidisciplinary primary health care clinicians and practitioners provide assessment, diagnosis, education and primary prevention for an array of orthopedic, musculoskeletal, sports injury, and neurological conditions. The NVOS stock yearly return is shown above.
The yearly return on the NVOS stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2023 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the NVOS annual return calculation with any dividends reinvested as applicable (on ex-dates).
|